Source:http://linkedlifedata.com/resource/pubmed/id/17617502
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
14
|
pubmed:dateCreated |
2007-7-9
|
pubmed:abstractText |
In an effort to minimize barriers to compliance and adherence and to improve the accuracy of dosage measurement, sugar-containing and sugar-free sodium phenylbutyrate suspensions were formulated, and the stability of these products over a 90-day period was determined.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Jul
|
pubmed:issn |
1535-2900
|
pubmed:author | |
pubmed:issnType |
Electronic
|
pubmed:day |
15
|
pubmed:volume |
64
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1513-5
|
pubmed:meshHeading | |
pubmed:year |
2007
|
pubmed:articleTitle |
Stability of extemporaneously prepared sodium phenylbutyrate oral suspensions.
|
pubmed:affiliation |
Pediatric Cardiothoracic Unit, University of Michigan Hospitals and Health Centers, Ann Arbor, MI 48109-0008, USA. rcaruthe@med.umich.edu
|
pubmed:publicationType |
Journal Article,
Comparative Study
|